BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16397452)

  • 1. Dementia with parkinsonism: what is the diagnosis?
    Chong MS; Vinters HV; Gustavson AR; Cummings JL
    Rev Neurol Dis; 2004; 1(1):41-4. PubMed ID: 16397452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia with parkinsonism.
    Chong MS; Klement IA; Vinters HV; Cummings JL
    Rev Neurol Dis; 2004; 1(2):97-101. PubMed ID: 16400266
    [No Abstract]   [Full Text] [Related]  

  • 3. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC; Diehl LA; Hedgepath AW
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract]   [Full Text] [Related]  

  • 4. Dementia with Lewy bodies: response of delirium-like features to donepezil.
    Kaufer DI; Catt KE; Lopez OL; DeKosky ST
    Neurology; 1998 Nov; 51(5):1512. PubMed ID: 9818904
    [No Abstract]   [Full Text] [Related]  

  • 5. The evolution and profile of dementia in Parkinson's disease.
    Ross HF; Hughes TA; Boyd JL; Biggins CA; Madeley P; Mindham RH; Spokes EG
    Adv Neurol; 1996; 69():343-7. PubMed ID: 8615150
    [No Abstract]   [Full Text] [Related]  

  • 6. Dementia treatment update.
    Buffum MD; Buffum JC
    Geriatr Nurs; 2005; 26(2):74-8. PubMed ID: 15824717
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of cognitive impairment following delayed CO encephalopathy.
    Song IU; Cho HJ; Kim YD; Chung SW
    Can J Neurol Sci; 2011 Nov; 38(6):934-5. PubMed ID: 22030437
    [No Abstract]   [Full Text] [Related]  

  • 8. [Alzheimer type dementia].
    Ruis J
    Rev Infirm; 2008 Sep; (143):14-5. PubMed ID: 18788658
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dementia following bipolar disorder].
    Lebert F; Lys H; Haëm E; Pasquier F
    Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dementia and/or depression].
    Nicoulaud L; Gallarda T
    Encephale; 2005 Oct; 31 Pt 2():S56-8. PubMed ID: 16673711
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive change in Parkinson disease.
    Galvin JE
    Alzheimer Dis Assoc Disord; 2006; 20(4):302-10. PubMed ID: 17132978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Kulisevsky J; García-Sánchez C; Pascual-Sedano B; Gironell A; Martínez-Corral M
    Mov Disord; 2008 Aug; 23(11):1546-50. PubMed ID: 18546326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric outcome for clinical trials.
    Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ
    J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
    [No Abstract]   [Full Text] [Related]  

  • 16. [Argyrophilic grain disease: synergistic component of dementia?].
    Wallon D; Sommervogel C; Laquerrière A; Martinaud O; Lecourtois M; Hannequin D
    Rev Neurol (Paris); 2010 Apr; 166(4):428-32. PubMed ID: 19963233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal dementia.
    Honig LS; Bell K; Chin SS
    Sci Aging Knowledge Environ; 2003 Apr; 2003(13):DN1. PubMed ID: 12844524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
    Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
    Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.